🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to round out our leadership team and continue pushing our mission forward! #RNA #research #biotech #firsttweet genevant.com/genevant-appoi…

Genevant Sciences is pleased to announce that our President & CEO Bo Rode Hansen will be the closing speaker at the OPT Congress in Boston on Wed, March 27th. Learn about the exciting accomplishments and future of nucleic acid delivery platforms with Genevant's Pan-RNA approach.

Genevant Sciences is pleased to announce that our President & CEO Bo Rode Hansen will be the closing speaker at the OPT Congress in Boston on Wed 3/27. Learn about the exciting future of nucleic acid delivery platforms with Genevant's Pan-RNA approach. #OPTBoston

We did it! Year 1 and many more. So proud of the work done by our 52 people strong across Cambridge and Vancouver building the future of RNA therapies. Congratulations everyone!

We are so excited to announce that Bo Rode Hansen, MBA, PhD, President and Chief Executive Officer of Genevant Sciences, is scheduled to present at the Jefferies 2019 Healthcare Conference in New York City on Friday, June 7, 2019 at 8:00 am EDT.

Thank you Oligonucleotide Therapeutics Society for a wonderful conference in Munich We were so pleased to announce our progress with BioNTech SE for the treatment of OTC at #otsmunich